Maybe with IND approval but probably after a succe
Post# of 36537
(Total Views: 405)
Posted On: 03/22/2021 8:27:19 AM
Maybe with IND approval but probably after a successful Phase1/2. Assuming NGIO's vaccine can back up it's safety, effectiveness and long term immunity claims someway other than Joe saying so on the Big Biz Show.
Wonder where the peer reviewed paper is?
Wonder where the peer reviewed paper is?
(7)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼